Rik Deitsch
Chairman and Chief Executive Officer
Nutra Pharma Corporation

Rik J. Deitsch has been the President, Chief Executive Officer and a Director of the Company since November 7, 2002. From February 1998 through November 2002, Mr. Deitsch served as the President of NDA Consulting Inc., a biotechnology research group that provided consulting services to the pharmaceutical industry. NDA Consulting specialized in the research of peptides derived from Cone Snail venom, Cobra venom and Gila Monster venom. Mr. Deitsch holds both a B.S. in Chemistry and an M.S. in Biochemistry from Florida Atlantic University and has conducted clinical and laboratory research in collaboration with scientists at Duke University Medical Center and the Cleveland Clinic . Mr. Deitsch is an adjunct professor and teaches several courses for Florida Atlantic University's College of Business and Continuing Education Department.

Paul F. Reid, Ph.D.
Chief Executive Officer
ReceptoPharm, Inc.

Paul F. Reid, Ph.D., is a Co-Founder and Chief Executive Officer of ReceptoPharm. Dr. Reid is equipped with a broad scientific background, encompassing 14+ years in clinical development and research, with a direct approach to moving products from preclinical into clinical phases. He has worked and negotiated with drug regulatory agencies in the US, Canada, EU, South America, South Africa, and China, enabling companies to move ahead, save millions on research and testing in clinical trials, and gain IND approvals. By leveraging his comprehensive understanding of regulatory requirements he can guide new projects through the correct protocols at a minimum budget, advancing products, positioning for licensing, and setting up manufacturing. The application of his knowledge of laboratory practices to select new technologies that enhance production, quality control, and product formats. Dr. Reid is a leading world expert in the therapeutic use of snake venom neurotoxins.

Neil Roth
President
Designer Diagnostics, Inc.

Neil Roth joined Nutra Pharma Corporation in 2005 as President of Designer Diagnostics, Inc. He has over 30 years experience in the sales and marketing of consumer goods including pharmaceuticals and medical devices. His prior experience included senior management and top marketing positions of major multibillion-dollar companies, including: Revco, Eckerd Drugs and Thrifty Drugs. He has successfully increased sales in the companies that he has been associated with through his expertise and understanding of the creation of marketing plans into new and developing markets.

David Isserman
Chief Marketing Officer
Nutra Pharma Corporation

David Isserman joined Nutra Pharma Corporation in 2010 as Chief Marketing Officer after serving the Company for several years as an outside consultant. Prior to Joining Nutra Pharma, Mr. Isserman served as President of Isserman Consulting, a boutique marketing communications consultancy that advised early-stage biotechnology, consumer products and technology companies, and was a co-founder of RareShare, a website developed to connect patients and healthcare providers affected by rare medical disorders.  Over the past several years, Mr. Isserman has served on several scientific and environmental non-profit boards and currently serves as a Trustee for the Academy of Science of St. Louis. Mr. Isserman received his Master of Business Administration (MBA) from Columbia Business School in New York.